Loading...

Intellectia LogoIntellectia
AI Trading Bot
Features
Markets
News
Resources
Pricing
Get Started
  1. Home
  2. Stock
  3. ARQQ
ARQQ logo

ARQQ Should I Buy

-
$
0.000
0.000(0.000%)
At close
0.000(0.000%)Aft-market
ET
$
0.000
0.000(0.000%)
At close
0.000(0.000%)Aft-market
ET
OverviewStock Price PredictionTechnicalValuationFinancialsEarningsShould I BuyNews & Events
an image of Intellectia Logoan image of Intellectia

Most Trusted AI Platform for Winning Trades

TwitterYoutubeQuoraDiscordLinkedinTelegram

Copyright © 2026 Intellectia.AI. All Rights Reserved.

Company

  • Home
  • Contact
  • About Us
  • Press
  • Privacy
  • Terms of Service
  • Service Terms of Use

Resources

  • Blog
  • Tutorial
  • Help Center
  • Affiliate Program

Markets

  • Market Analysis
  • Crypto
  • Featured Screeners
  • AI Earnings Calendar
  • Market Movers
  • Stock Monitor
  • Economic Calendar
  • All US Stocks
  • All Cryptos

Tools

  • Dividend Calculator
  • Dividend Yield Calculator
  • Options Profit Calculator

Features

  • QuantAI Alpha Pick
  • SwingMax Portfolio
  • Swing Trading
  • AI Stock Picker
  • Whales Auto Tracker
  • Daytrading Center
  • Patterns Detection
  • AI Screener
  • Financial AI Agent
  • Backtesting Playground
  • AI Earnings Prediction
  • Stock Monitor
  • Technical Analysis

News

  • Overview
  • Top News
  • Daily Market Brief
  • Earnings Analysis
  • Newswire
  • Stock News
  • Crypto News
  • Institution News
  • Congress News
  • Monitor News

Compare

  • TradingView
  • SeekingAlpha
Intellectia

Should You Buy Arqit Quantum Inc (ARQQ) Today? Analysis, Price Targets, and 2026 Outlook.

Conclusion
Hold
Latest Price
11.990
1 Day change
1.78%
52 Week Range
62.000
Analysis Updated At
2026/03/26
Should I buy Analysis is updated weekly. For real time "Should I Buy" analysis, please sign up to get free answers.
Sign Up

Arqit Quantum Inc (ARQQ) is not a strong buy for a beginner, long-term investor at this time. The stock exhibits bearish technical indicators, lacks positive trading signals, and has no significant catalysts or financial data to support a buy decision. The investor should wait for clearer bullish signals or improved fundamentals before considering an entry.

Technical Analysis

The stock is exhibiting bearish technical indicators. The MACD histogram is positive but contracting, indicating weakening momentum. The RSI is at 27.554, which is neutral but approaching oversold territory. Moving averages are bearish, with SMA_200 > SMA_20 > SMA_5. Key support is at 12.495, and the stock is trading near support levels, suggesting potential downside risk.

Options Data

Bullish
Open Interest Put-Call Ratio
Bullish
Option Volume Put-Call Ratio

Options data indicates a strong bias toward calls, with a low Put-Call ratio and significantly higher call volume. However, implied volatility is high (108.2), suggesting elevated risk.

Technical Summary

StrongSellSellNeutralBuyStrongBuydotted line Image
Sell
9
Buy
5

Positive Catalysts

  • No positive catalysts identified. There is no recent news, no significant insider or hedge fund activity, and no recent congress trading data.

Neutral/Negative Catalysts

  • The stock has experienced a significant price decline (-6.24% in regular trading) and is trading below key moving averages. Broader market sentiment is negative, with the S&P 500 down 1.79%.

Financial Performance

No financial data or valuation metrics are available for analysis. The latest quarter financials could not be assessed.

Growth

Profitability

Efficiency

Analyst Ratings and Price Target Trends

No data on analyst ratings or price target changes is available for ARQQ.

Wall Street analysts forecast ARQQ stock price to rise
1 Analyst Rating
Wall Street analysts forecast ARQQ stock price to rise
1 Buy
0 Hold
0 Sell
Moderate Buy
Current: 11.780
sliders
Low
60
Averages
60
High
60
Current: 11.780
sliders
Low
60
Averages
60
High
60
Evercore ISI
Evercore ISI
Outperform
initiated
$44
AI Analysis
2025-12-03
Reason
Evercore ISI
Evercore ISI
Price Target
$44
AI Analysis
2025-12-03
initiated
Outperform
Reason
Welcome to the latest edition of "Quantum Leap" where The Fly decodes news and activity in the quantum computing space.DATA TRANSMISSION:Arqit Quantumand Sparkle demonstrated quantum-resilient data transmission across Sparkle's optical network in Greece. The proof of concept, implemented over Sparkle metropolitan optical ring in Athens, shows how Arqit's encryption technology can be embedded directly into the optical transport layer, protecting high-capacity networks against future quantum threats without impacting performance. Sparkle validated that sensitive data can be secured at the physical network layer without compromising performance. Following the deployment of Arqit's technology, end-to-end encryption was applied to multi-100G optical links. This demonstrated that quantum-resistant protection can be delivered at the speed of light.GOVERNMENT BUSINESS UNIT:D-Wave Quantumannounced that it has formed a new business unit dedicated to driving the adoption of its quantum computing products and services with the U.S. government. In support of the company's government business, D-Wave recently announced that its Advantage2 quantum computer is now operational at the Alabama headquarters of Davidson Technologies, a technology company supporting U.S. Department of War and commercial aerospace customers. The system is expected to address mission-critical U.S. government problems and eventually run sensitive applications. "D-Wave is uniquely positioned to address many of the challenges facing our government," said Jack Sears, VP of U.S. government solutions. "With D-Wave's quantum technology capable of solving real-world problems today and a quantum computing system operational in Alabama that is expected to eventually handle sensitive applications, now is the time to aggressively push quantum adoption in service of national security and defense."INVESTMENT PARTNERSHIP:IonQannounced an investment partnership with the Centre for Commercialization of Regenerative Medicine, or CCRM, to accelerate therapeutic development using hybrid quantum and quantum-AI technologies. The partnership includes an investment commitment into CCRM's new quantum-biotech initiatives and establishes IonQ as the technology partner across CCRM's global network of therapy hubs. This collaboration will initially focus on areas including bioprocess optimization, disease-modeling workflows, and quantum enhanced simulation to support the design and manufacturing of advanced therapies.STRATEGIC ROADMAP:Sealsqannounced that it organized a gathering in Provence to outline its vision for 2026/2030. Year-to-date growth has been supported primarily by renewed demand for Sealsq's core products and the consolidation of two months of revenue from IC'Alps, following its acquisition on August 4. Sealsq also presented its strategic roadmap for 2026. With more than EUR 450M in cash reserves, the company said it is positioned to accelerate its expansion through potential targeted acquisitions, planned new product lines, and continued innovation. According to the company, these initiatives support Sealsq's long-term 2030 goal: the development of its own secure sovereign quantum computer.ANALYST COMMENTARY:Evercore ISI initiated coverage of D-Wave Quantum with an Outperform rating and $44 price target. The firm, which views D-Wave as "a leading play" as the computing industry shifts to a quantum computing era, highlights it as the first quantum company with commercial revenues, a full stack ecosystem and one that is well-funded.UBS hosted a gate quantum panel with IonQ, Rigetti Computingand Quantum Computing. The firm noted the following key themes:Engineering hurdles remain; financing is often the bottleneck.Commercialization likely four to five years away; path unclear.Divergent views on networking, memory, and synergy with classical computing.Post-quantum security assumptions may shift as QPU capabilities evolve.

People Also Watch